Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A



Status:Completed
Conditions:Shingles, Infectious Disease
Therapuetic Areas:Dermatology / Plastic Surgery, Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:1/24/2018
Start Date:July 13, 2012
End Date:February 1, 2017

Use our guide to learn which trials are right for you!

Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A

The purpose of this study is to evaluate the efficacy of GSK Biologicals' vaccine GSK1437173A
in the prevention of Herpes zoster (HZ) in autologous haematopoietic cell transplant
recipients 18 years of age and older. To this end, the study will evaluate vaccine efficacy
(VE) of the GSK1437173A vaccine, administered on a 2-dose schedule, compared to placebo in
reducing the risk of developing HZ in this population.


Inclusion Criteria:

Study entry (enrollment) occurs at the Pre-vaccination visit.

- Subjects who the investigator believes can and will comply with the requirements of
the protocol.

- Written informed consent obtained from the subject.

- A male or female aged 18 years or older at the time of study entry.

- Has undergone or will undergo autologous HCT within 50-70 days prior to the first
vaccination with the study vaccine/placebo, and there are no plans for additional
HCTs.

- Female subjects of non-childbearing potential may be enrolled in the study. For this
study population, non-childbearing potential is defined as current tubal ligation,
hysterectomy, ovariectomy or post-menopause.

OR Female subjects of childbearing potential may be enrolled in the study, if the subject
has practiced adequate contraception for 30 days prior to vaccination with the study
vaccine/placebo, and has a negative pregnancy test on the day of vaccination, and has
agreed to continue adequate contraception during the entire treatment period and for 12
months after completion of the vaccination series (i.e., until Month 13).

Exclusion Criteria:

- Use of any investigational or non-registered product other than the study vaccine
within 30 days preceding the first dose of study vaccine/placebo, or planned use
during the study period. However, the investigational use of a registered or
non-registered product to treat the subject's underlying disease for which the HCT was
undertaken, or a complication of the underlying disease, is allowed.

- Previous vaccination against HZ or varicella within the 12 months preceding the first
dose of study vaccine/placebo.

- Planned administration during the study of a HZ vaccine other than the study vaccine.

- Occurrence of a varicella or HZ episode by clinical history within the 12 months
preceding the first dose of study vaccine/placebo.

- History of allergic disease or reactions likely to be exacerbated by any component of
the vaccine or study material and equipment.

- Prophylactic antiviral therapy with activity against Varicella Zoster Virus (VZV)
expected to last more than 6 months after transplantation.

- Administration and/or planned administration of a vaccine not foreseen by the study
protocol between HCT and 30 days after the last dose of study vaccine/placebo.
However, licensed non-replicating vaccines may be administered up to 8 days prior to
dose 1and/or 2, and/or at least 14 days after any dose of study vaccine/placebo.

- HIV infection by clinical history.

- Pregnant or lactating female.

- Female planning to become pregnant or planning to discontinue contraceptive
precautions (if of childbearing potential) before Month 13 (i.e., one year after the
last dose of study vaccine/placebo).
We found this trial at
24
sites
Syracuse, New York 13210
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Aurora, Colorado 80010
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cleveland, Ohio 44195
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dallas, Texas 75230
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Darlinghurst, New South Wales 2010
?
mi
from
Darlinghurst,
Click here to add this to my saved trials
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Duarte, California 91010
?
mi
from
Duarte, CA
Click here to add this to my saved trials
Durham, North Carolina 27705
?
mi
from
Durham, NC
Click here to add this to my saved trials
Hackensack, New Jersey 07601
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Lexington, Kentucky 40504
?
mi
from
Lexington, KY
Click here to add this to my saved trials
Marshfield, Wisconsin 54449
?
mi
from
Marshfield, WI
Click here to add this to my saved trials
Minnesota, Minnesota 55455
?
mi
from
Minnesota, MN
Click here to add this to my saved trials
New York, New York 10032
?
mi
from
New York, NY
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
San Francisco, California 94115
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Seattle, Washington 98109
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Seattle, Washington 98109
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Westwood, Kansas 66205
?
mi
from
Westwood, KS
Click here to add this to my saved trials